Search - tctmd.com

Displaying 101 - 120 of 214

Sort: Relevancy | Date

Presentation TVT 2021

Complex Valve-in-Valve (Stentless, External Wrap, etc)

Presenter: Amar Krishnaswamy

July 21, 2021

Presentation TVT 2021

Two for the Price of One: Mixed Valvular and Subvalvular Gradient

Presenter: Vivian Ng

July 21, 2021

Presentation TVT 2021

Two Is More Than Three: Challenging Bicuspid Anatomy

Presenter: Mathew Williams

July 21, 2021

Presentation TVT 2021

How Low Can You Go? Low Left Main and/or Effaced Sinus Without Basilica

Presenter: Duane Pinto

July 21, 2021

Presentation TVT 2021

Between a Rock and a Hard Place: Calcium, Calcium, and More Calcium

Presenter: John Forrest

July 21, 2021

Presentation TVT 2021

The Future Role of TAVR in AR Therapy: Mapping an Evidence-Based Pathway

Presenter: Ori Ben-Yehuda

July 21, 2021

Presentation TVT 2021

Quantitative Assessment of AR Severity by Echo: A Multi-parametric Approach

Presenter: Nadira Hamid

July 21, 2021

Presentation TVT 2021

Updates From the ALIGN-AR Global Clinical Program

Presenter: Torsten Vahl

July 21, 2021

Presentation TVT 2021

Case Presentation 2: High-Risk Severe AR with JenaValve TAVR

Presenter: Lauren Ranard

July 21, 2021

Presentation TVT 2021

Case Presentation 1: High-Risk Severe AR with Commercially-Approved TAVR

Presenter: Tom Cahill

July 21, 2021

Presentation TVT 2021

Characterizing the Transcatheter Clinical Need: Prevalence of Severe AR and Surgical Alternatives

Presenter: Vinod Thourani

July 21, 2021

Presentation TVT 2021

MASTER CLASS #6 Coronaries and TAVR – A Growing Dilemma (Coronary Access, When to PCI, High-Risk for Closure Anatomy; Case-Based)

Presenter: Steven Yakubov

July 21, 2021

Presentation TVT 2021

Predictions on Late TAVR Failure Modes: Management Strategies and Innovation Opportunities

Presenter: Tsuyoshi Kaneko

July 21, 2021

#TAVR Case Reports on Twitter Paint Overly Optimistic Picture

News Daily News

#TAVR Case Reports on Twitter Paint Rosy Picture

Caitlin E. Cox

July 21, 2021

Presentation TVT 2021

MASTER CLASS #5: TAVR Alternative Access – Options, Featuring the Trans-Axillary Approach (Step-by-step) and Trans-Caval

Presenter: James McCabe

July 21, 2021

Presentation TVT 2021

A Critical Appraisal of the New TAVR Systems

Presenter: Eberhard Grube

July 21, 2021

Presentation TVT 2021

Portico FlexNav Updates

Presenter: Gregory Fontana

July 21, 2021

Presentation TVT 2021

Accurate Neo 2 Updates

Presenter: Lars Sondergaard

July 21, 2021

Presentation TVT 2021

Hemodynamic Consideration of SAVR &ViV-TAVR

Presenter: Tsuyoshi Kaneko

July 21, 2021

Presentation TVT 2021

Does Medical Therapy Make a Difference: Anti-Platelet and Anti-Thrombotic Therapy After TAVR

Presenter: George Dangas

July 21, 2021

Advertisement

Complex Valve-in-Valve (Stentless, External Wrap, etc)

Two for the Price of One: Mixed Valvular and Subvalvular Gradient

Two Is More Than Three: Challenging Bicuspid Anatomy

How Low Can You Go? Low Left Main and/or Effaced Sinus Without Basilica

Between a Rock and a Hard Place: Calcium, Calcium, and More Calcium

The Future Role of TAVR in AR Therapy: Mapping an Evidence-Based Pathway

Quantitative Assessment of AR Severity by Echo: A Multi-parametric Approach

Updates From the ALIGN-AR Global Clinical Program

Case Presentation 2: High-Risk Severe AR with JenaValve TAVR

Case Presentation 1: High-Risk Severe AR with Commercially-Approved TAVR

Characterizing the Transcatheter Clinical Need: Prevalence of Severe AR and Surgical Alternatives

MASTER CLASS #6 Coronaries and TAVR – A Growing Dilemma (Coronary Access, When to PCI, High-Risk for Closure Anatomy; Case-Based)

Predictions on Late TAVR Failure Modes: Management Strategies and Innovation Opportunities

#TAVR Case Reports on Twitter Paint Rosy Picture

MASTER CLASS #5: TAVR Alternative Access – Options, Featuring the Trans-Axillary Approach (Step-by-step) and Trans-Caval

A Critical Appraisal of the New TAVR Systems

Portico FlexNav Updates

Accurate Neo 2 Updates

Hemodynamic Consideration of SAVR &ViV-TAVR

Does Medical Therapy Make a Difference: Anti-Platelet and Anti-Thrombotic Therapy After TAVR

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content